Literature DB >> 26399245

[Economic importance of postoperative urinary incontinence].

V Lent1, M Schultheis2.   

Abstract

In the 22,160 patients treated in Germany for prostate cancer by prostatectomy, the costs for direct and indirect sequelae as the result of postoperative urinary incontinence are estimated to be 71.8 million €. This greatly exceeds the costs of 69.8 million € for the operation itself. This additional economic burden can, however, be decisively influenced by using a surgical technique that preserves the integrity of the urethral sphincter.

Entities:  

Keywords:  Prostate cancer; Prostatectomy; Prostatectomy, retropubic; Urethral sphincter; Urinary incontinence, stress

Mesh:

Year:  2015        PMID: 26399245     DOI: 10.1007/s00120-015-3856-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  19 in total

1.  Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States.

Authors:  Karin S Coyne; Marion Kvasz; Andrea M Ireland; Ian Milsom; Zoe S Kopp; Chris R Chapple
Journal:  Eur Urol       Date:  2011-07-26       Impact factor: 20.096

Review 2.  The economic burden of prostate cancer.

Authors:  Claus G Roehrborn; Libby K Black
Journal:  BJU Int       Date:  2011-09       Impact factor: 5.588

3.  Population based study of long-term rates of surgery for urinary incontinence after radical prostatectomy for prostate cancer.

Authors:  Robert K Nam; Sender Herschorn; D Andrew Loblaw; Ying Liu; Laurence H Klotz; Lesley K Carr; Ronald T Kodama; Aleksandra Stanimirovic; Vasundara Venkateswaran; Refik Saskin; Calvin H L Law; David R Urbach; Steven A Narod
Journal:  J Urol       Date:  2012-06-15       Impact factor: 7.450

4.  The burden of out-of-pocket and indirect costs of prostate cancer.

Authors:  Ravishankar Jayadevappa; J Sanford Schwartz; Sumedha Chhatre; Joseph J Gallo; Alan J Wein; S Bruce Malkowicz
Journal:  Prostate       Date:  2010-08       Impact factor: 4.104

5.  Economic costs of urinary incontinence in 1995.

Authors:  T H Wagner; T W Hu
Journal:  Urology       Date:  1998-03       Impact factor: 2.649

6.  Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.

Authors:  Richard Olivier Fourcade; Agnes Benedict; Libby K Black; Michael E Stokes; Antonio Alcaraz; Ramiro Castro
Journal:  BJU Int       Date:  2010-01       Impact factor: 5.588

7.  Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder.

Authors:  Derek H Tang; Danielle C Colayco; Kristin M Khalaf; James Piercy; Vaishali Patel; Denise Globe; David Ginsberg
Journal:  BJU Int       Date:  2014-03       Impact factor: 5.588

8.  Health related quality of life significance of single pad urinary incontinence following radical prostatectomy.

Authors:  Matthew R Cooperberg; Viraj A Master; Peter R Carroll
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

9.  Economic burden of cancer across the European Union: a population-based cost analysis.

Authors:  Ramon Luengo-Fernandez; Jose Leal; Alastair Gray; Richard Sullivan
Journal:  Lancet Oncol       Date:  2013-10-14       Impact factor: 41.316

10.  Lifetime economic burden of prostate cancer.

Authors:  Michael E Stokes; Jack Ishak; Irina Proskorovsky; Libby K Black; Yijian Huang
Journal:  BMC Health Serv Res       Date:  2011-12-28       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.